Sickle Cell Trait and Vaso-occlusive Crisis

Understanding Sickle Cell Trait vs. Sickle Cell Disease

The Association of Anaesthetists guidelines categorize sickle cell trait as "benign" in their classification table of sickle cell disease and related hemoglobinopathies 1
Sickle cell trait is the heterozygous carrier state where individuals have 55-65% normal adult hemoglobin and only 30-40% sickle hemoglobin, which is generally considered benign 1, 2
Sickle cell disease genotypes have much higher percentages of sickle hemoglobin and are associated with clinical manifestations 1, 3

Vaso-occlusive crises occur due to extensive polymerization of sickle hemoglobin molecules when deoxygenated, causing red blood cells to deform into the characteristic sickle shape 1, 3
The sickling process in sickle cell disease leads to damage to red cell membranes and cytoskeleton, formation of irreversibly sickled cells, red cell hemolysis, increased adherence to vascular endothelium, and vaso-occlusion, ischemia-reperfusion injury, and end-organ damage 1, 2, 3

In sickle cell trait, the presence of 55-65% normal hemoglobin provides protection against sickling under normal physiological conditions 1, 3
The limited amount of sickle hemoglobin in sickle cell trait is insufficient to trigger the extensive polymerization required for clinically significant vaso-occlusion 1, 2

Individuals with sickle cell trait do not require the same monitoring and precautions as those with sickle cell disease 1, 4
Pre-operative screening should identify those with sickle cell trait, but they do not need the specialized management protocols required for sickle cell disease patients 1, 4